In the news...

October 15th, 2019

Cutting-edge gene-editing techniques such as Crispr-Cas9 will enable scientists to make precise genetic changes to pig physiology, they say, leading to animals impervious to common maladies such as porcine reproductive and respiratory syndrome, a virus that costs the U.S. pork industry hundreds of millions of dollars a year.

“It has the potential for being a great tool,” says Gordon Spronk, a veterinarian and chairman of Pipestone Holdings LLC, a Minnesota hog-breeding company. Producing pigs that aren’t susceptible to common ailments would be a big advantage, he says. Read more …